© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 17, 2021
Apremilast has been prescribed to more than 250,000 patients with plaque psoriasis or psoriatic arthritis since it was approved in 2014.
January 05, 2021
The IL-23 inhibitor is shown to improve disease activity across joint and skin symptoms.
December 04, 2020
It is feasible to discontinue methotrexate in patients who had received tofacitinib combination therapy.
December 03, 2020
November 12, 2020
A pediatric dermatologist discusses her experience managing and treating psoriasis in children.
November 10, 2020
Favorable phase 2 results with the TYK2 inhibitor for psoriatic arthritis at ACR 2020 coincided with announced positive phase 3 trial results for psoriasis.
September 30, 2020
This approval makes the drug the first of its kind to treat polyarticular juvenile idiopathic arthritis and psoriatic arthritis in a pediatric population.
September 14, 2020
Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.
Which composite measures detect the highest level of changes in psoriatic disease activity.
September 12, 2020
When a rheum patient might need to consult with a dermatologist.